Skip to main content
. 2016 Mar;77:38–46. doi: 10.1016/j.peptides.2015.10.008

Table 1.

Baseline characteristics of study participants—characteristics shown as median (range). HV: healthy volunteers; T2DM: patients with type 2 diabetes mellitus.

HV: assessment of GLP-1 concentrations
= 10
HV: assessment of glucose tolerance
n = 9
HV: assessment of meal sizea
n = 10
T2DM: assessment of glucose tolerance
n = 8
Gender 5 male, 5 female 4 male, 5 female 5 male, 5 female 4 male, 4 female
Age (years at enrolment) 31.3 (9.7) 36.2 (10.5) 33.9 (10.2) 57.9 (10.7)
Body Mass Index (kg/m2) 22.9 (3.5) 25.0 (3.9) 23.4 (4.1) 32.5 (5.6)
Waist circumference (cm) 79.0 (14.0) 88.3 (11.5) 83.1 (15.5) 104.0 (16.8)
Hip circumference (cm) 94 (10) 102 (8) 96 (11) 120 (10)
DXA percentage fat mass 23.8 (11.3) 29.3 (12.5) 29.1 (12.4) 41.8 (8.0)
Hemoglobin (g/l) 136 (13) 138 (14) 135 (15) 136 (16)
White Cell Count *109/l 5.1 (0.7) 5.3 (1.1) 4.8 (1.0) 6.7 (1.0)
Platelets *109/l 189 (25) 225 (52) 197 (30) 165 (82)
Creatinine (μmol/l) 70.5 (11.8) 67.3 (11.0) 64.0 (8.9) 70.9 (10.4)
ALT (IU/l) 32.5 (23.8) 36.4 (25.9) 33.6 (27.6) 46.0 (23.3)
TSH (U/l) 2.0 (0.8) 2.1 (0.6) 2.0 (0.9) 1.9 (1.0)
HbA1c (mmol/mol) 36.0 (4.2) 36.9 (3.4) 36.4 (3.6) 57.6 (17.6)
a

Only 8 of these participants had blood taken and a DXA scan.